CELLPHIRE
Cellphire has developed a proprietary method for the stabilization of blood in the dry state Current efforts and product development are aimed toward stabilized platelets for advanced wound care, transfusion, and reagent products for clinical and research diagnostics. We have been able to stabilize and modify platelets into a hemostatic agent that can be stored well beyond the current limit of 5 days. Platelets cannot be stockpiled and shortages occur because of this extremely short shelf ... life. These shortages can interrupt the treatment of cancer patients and actively bleeding surgical or trauma patients. The fragility of the national supply of platelets is a topic of discussion of several task forces and agencies planning the nation's response to a pandemic such as avian influenza. This and other natural or manmade disasters would interrupt or exceed the available supply of platelets that is needed to maintain an adequate supply or treat bleeding casualties.
CELLPHIRE
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2005-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.cellphire.com
Total Employee:
11+
Status:
Active
Contact:
2402681145
Email Addresses:
[email protected]
Total Funding:
16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Global Site Tag Euro Cloudflare JS CDN JS
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Current Advisors List
Current Employees Featured
Founder
Investors List
Simcah Management
Simcah Management investment in Series A - CellPhire
Maryland Venture Fund
Maryland Venture Fund investment in Debt Financing - CellPhire
Official Site Inspections
http://www.cellphire.com Semrush global rank: 2.1 M Semrush visits lastest month: 9.79 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "CellPhire"
About Us - Cellphire
CellPhire - Crunchbase Company Profile & Funding
Cellphire has developed a proprietary method for the stabilization of blood in the dry state. Current efforts and product development are aimed toward …See details»
Cellphire Therapeutics, Inc. | LinkedIn
Cellphire Therapeutics, Inc. | 1,562 followers on LinkedIn. Revolutionizing Platelet-Based Therapies | Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology …See details»
Leadership Bios - Cellphire
He joined Cellphire in 2006 and has led the development of the company’s first line of hemostatic products. Prior to joining Cellphire, Dr. Fitzpatrick served as Chief Operating Officer of …See details»
CellPhire Therapeutics 2025 Company Profile: …
CellPhire Therapeutics was founded in 2005. Where is CellPhire Therapeutics headquartered? CellPhire Therapeutics is headquartered in Rockville, MD. What is the size of CellPhire Therapeutics? CellPhire Therapeutics has 50 total …See details»
Cellphire - Overview, News & Similar companies | ZoomInfo.com
May 27, 2021 Cellphire Therapeutics Treats First Patient in Phase 2/3 Cryopreserved Platelets Clinical Trial ROCKVILLE, Md., March 29, 2022 /PRNewswire/ -- Cellphire Therapeutics, Inc., …See details»
Cellphire, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cellphire, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 4 news, and 6 literature, Disease Domain:Hemic and Lymphatic Diseases, Nervous System …See details»
CellPhire - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... obfuscated — Apr 2, 2021: Series A - CellPhire . 1: …See details»
Cellphire Therapeutics, Inc. Overview - SignalHire
By Q2 2021, Cellphire Therapeutics, Inc. has participated in at least 6 funding rounds and has raised a minimum of 48.1M. Funding increased noticeable in Q2 2021 — by 14.7M compared …See details»
Cellphire Therapeutics - Org Chart, Teams, Culture
Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to …See details»
CellPhire - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 25, 2025 Cellphire has filed a notice of an exempt offering of securities to raise $8,000,000.00 in New Debt Financing.intelligence360 • Oct 10, 2023 • CellPhire Stephen …See details»
Cellphire Revenue, Growth & Competitor Profile - IncFact.com
Mar 10, 2025 Trademark applications show the products and services that Cellphire is developing and marketing. Cellphire doesn't have any recent trademark applications, …See details»
CellPhire - Updates, News, Events, Signals & Triggers - Crunchbase
CellPhire may be growing as it is listed among key players in the choroidal neovascularization drug market, which suggests recognition in its field. The company is also mentioned in the …See details»
Cellphire
Apr 5, 2021 “Cellphire has grown significantly over the past 16 years, and it is time to reflect that growth and our success in our brand identity,” said Rafael Jorda, Interim CEO, Cellphire …See details»
Cellphire’s Competitors, Revenue, Number of Employees ... - Owler
Cellphire’s Profile, Revenue and Employees. Cellphire is a Maryland-based biotechnology company that develops and commercializes stabilized cellular materials to treat bleeding and …See details»
CEO & President at Cellphire Therapeutics - The Org
Prior to joining Cellphire, Mr. Gaffney founded Bancroft Group, LLC, a strategy and operational consulting business focused on middle market companies and their investors. In addition to …See details»
Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding …
ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million …See details»
Cellphire
Apr 3, 2017 About Cellphire. Cellphire, Inc. is a biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology …See details»
Cellphire
Rockville, Md. (February 18, 2025) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation platelet-derived therapies, today announced the …See details»